Evidence map›Paper›PMID 41326431›Full record

ArticleScientific reports2025

Electrospinning of core shell nanofibers using amine modified sericins.

Demet Sezgin Mansuroglu, Adem Çınarlı, Gökhan Çaylı, Demet Gurbuz

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Demet Sezgin MansurogluCentral Laboratory, Kocaeli University, 41001, Kocaeli, Türkiye.
Adem ÇınarlıDepartment of Chemistry, Engineering Faculty, Istanbul University-Cerrahpaşa, 34320, Avcılar, Istanbul, Turkey. adem@iuc.edu.tr.
Gökhan ÇaylıDepartment of Engineering Sciences, Engineering Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
Demet GurbuzDepartment of Chemistry, Engineering Faculty, Istanbul University-Cerrahpaşa, 34320, Avcılar, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study as a renewable resorce, silk sericin (SS), a protein surrounding fibroin fibers in silk, was chemically modified with various amines (e.g., methylamine, butylamine) to improve its functional properties. These modifications, which included nucleophilic substitution reactions, improved its thermal stability, mechanical strength, and biological activity by substituting primary amine groups in place of hydroxyl ions in the structure. Modified SS (M-SS) was then used to produce nanofiber membranes via coaxial electrospinning. In this process, polyvinyl alcohol (PVA) served as the hydrophilic and SS/M-SS carrier polymer to delay biodegradation, while hydrophobic polylactic acid (PLA) and polycaprolactone (PCL) formed the shell to enhance mechanical strength and provide minimum adhesion to wounded tissues. This technique enabled the stable fabrication of core–shell nanofibers containing SS/M-SS, which are typically difficult to electrospin alone. Among the M-SS variants, methylamine-modified sericin (SMAT) yielded nanofibers with the highest tensile strength (0.673 MPa) and 6.44% elongation. The highest thermal resistance was observed in methylamine (SNF7) and butylamine (SNF9) modifications, with SNF7 showing 5% mass loss at 250 °C. The lowest resistance was seen in benzylamine-modified fibers (SNF11) at 220 °C. SNF9 also exhibited the highest cell viability, indicating its potential for biomedical applications.

Indexed as

ElectrospinningMaterial characterizationNanofibercompositesNanofibersNanomaterialsNucleophilic substitutionSericin modification

Identifiers

PMID41326431
PMCPMC12669752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.